Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 303

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Survival of patients with severe congestive heart failure treated with oral milrinone

Open access
Baim, Donald S., Colucci, Wilson S., Monrad, E. Scott, Smith, Harton S., Wright, Richard F., Lanoue, Alyce, Gauthier, Diane F., Ransil, Bernard J., Grossman, William, Braunwald, Eugene·1986·Journal of the American College of Cardiology

Abstract

The safety and efficacy of long-term oral milrinone therapy were evaluated over a 2 1/2 year period in 100 patients who had severe congestive heart failure despite conventional therapy. Long-term oral milrinone therapy (27 +/- 8 mg/day initial dose) was well tolerated; drug-related side effects occurred in only 11% of patients and led to drug withdrawal in only 4% of patients. Of 94 patients evaluated after 1 month of therapy, 51% had improved by at least one New York Heart Association functional class. Despite hemodynamic and clinical improvements, life table analysis showed a 39% mortality rate at 6 months and a 63% mortality rate at 1 year of therapy. Characteristics at study entry that predicted death within 6 months included more advanced functional class, impaired renal function, lower right ventricular ejection fraction, presence of nonsustained ventricular tachycardia on 24 hour ambulatory electrocardiography, more impaired baseline hemodynamic function and absence of clinical improvement after 1 month of milrinone therapy. Multivariate analysis selected lower baseline cardiac index and aortic systolic pressure as the most significant variables in predicting death; patients who died of progressive heart failure had less frequent use of antiarrhythmic drugs and greater increases in furosemide and milrinone doses during long-term follow-up than did those who died suddenly. Thus, although milrinone is well tolerated and produces early symptomatic benefits in approximately half of patients with congestive heart failure refractory to conventional therapy, there is no evidence that it improves the high baseline mortality in this disorder.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0735-1097(86)80478-8

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 303

Metadata

Authors
Baim, D. S., Colucci, W. S., Monrad, E. S., Smith, H. S., Wright, R. F., Lanoue, A., Gauthier, D. F., Ransil, B. J., Grossman, W., & Braunwald, E.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
1986-03
Volume
7
Issue
3
Pages
661-670
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2047098613
Cited by
303
References
32
FWCI
6.90
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Survival of patients with severe congestive heart failure treated with oral milrinone. https://app.cochat.ai/papers/10.1016/s0735-1097(86)80478-8
The paper
Baim, D. S., Colucci, W. S., Monrad, E. S., Smith, H. S., Wright, R. F., Lanoue, A., Gauthier, D. F., Ransil, B. J., Grossman, W., & Braunwald, E. (1986). Survival of patients with severe congestive heart failure treated with oral milrinone. Journal of the American College of Cardiology. https://doi.org/10.1016/s0735-1097(86)80478-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.